IRIS
STROMILLO, MARIA LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.761
EU - Europa 6.887
AS - Asia 3.753
SA - Sud America 678
AF - Africa 238
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 20.338
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.651
GB - Regno Unito 1.851
CN - Cina 1.261
RU - Federazione Russa 1.212
SG - Singapore 1.191
IT - Italia 832
IE - Irlanda 808
BR - Brasile 556
SE - Svezia 453
FR - Francia 448
UA - Ucraina 438
VN - Vietnam 365
HK - Hong Kong 341
DE - Germania 321
FI - Finlandia 200
KR - Corea 185
ZA - Sudafrica 140
IN - India 90
NL - Olanda 72
ES - Italia 69
CA - Canada 50
TR - Turchia 48
AR - Argentina 39
BD - Bangladesh 39
BE - Belgio 38
MX - Messico 36
IQ - Iraq 32
JP - Giappone 32
NG - Nigeria 32
PL - Polonia 23
AT - Austria 20
CO - Colombia 20
PK - Pakistan 20
PH - Filippine 19
EC - Ecuador 16
ID - Indonesia 16
MK - Macedonia 15
CI - Costa d'Avorio 13
KE - Kenya 13
MA - Marocco 13
CL - Cile 12
SA - Arabia Saudita 12
JO - Giordania 11
VE - Venezuela 11
AU - Australia 10
CZ - Repubblica Ceca 10
IL - Israele 9
IR - Iran 9
UZ - Uzbekistan 9
CH - Svizzera 8
GR - Grecia 8
MY - Malesia 8
NP - Nepal 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
KZ - Kazakistan 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
LT - Lituania 6
PY - Paraguay 6
AL - Albania 5
AZ - Azerbaigian 5
DZ - Algeria 5
EU - Europa 5
HU - Ungheria 5
RO - Romania 5
RS - Serbia 5
UY - Uruguay 5
BB - Barbados 4
EG - Egitto 4
LB - Libano 4
MD - Moldavia 4
PE - Perù 4
TN - Tunisia 4
AM - Armenia 3
DK - Danimarca 3
ET - Etiopia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
KG - Kirghizistan 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
SI - Slovenia 2
TH - Thailandia 2
Totale 20.318
Salva come PNG Salva come JPEG
Città #
Southend 1.639
Dallas 987
Fairfield 959
Dublin 801
Ashburn 671
Singapore 663
Chandler 469
Woodbridge 468
Menlo Park 439
Santa Clara 427
Houston 385
Wilmington 378
Seattle 365
Jacksonville 355
Cambridge 331
Beijing 321
Hong Kong 320
Moscow 306
San Jose 225
Hefei 215
Seoul 180
Siena 177
Princeton 165
Ann Arbor 163
The Dalles 139
Johannesburg 129
Los Angeles 126
Milan 121
Nanjing 118
Helsinki 106
Ho Chi Minh City 106
Hanoi 102
Lauterbourg 89
New York 79
Council Bluffs 74
Boardman 58
São Paulo 52
Málaga 51
San Mateo 51
Florence 47
San Diego 46
Buffalo 42
Dong Ket 40
London 38
Nanchang 38
Lancaster 37
Shenyang 35
Columbus 34
Orem 33
Rome 33
Abuja 30
Frankfurt am Main 30
Munich 28
Brussels 27
Shanghai 27
Redondo Beach 26
Tianjin 26
Tokyo 26
Bengaluru 23
Düsseldorf 23
Norwalk 22
Changsha 20
Chicago 20
Chennai 19
Hebei 19
Kunming 19
Rio de Janeiro 19
Toronto 19
Jiaxing 18
Phoenix 18
Stockholm 18
Jinan 17
San Francisco 17
Amsterdam 16
Belo Horizonte 16
Warsaw 16
Dearborn 15
Pisa 15
Baghdad 14
Boston 14
Denver 14
Lappeenranta 14
Nuremberg 14
Abidjan 13
Poplar 13
Brasília 12
Brooklyn 12
Fremont 12
Genoa 12
Guarulhos 12
Izmir 12
Turku 12
Amman 11
Da Nang 11
Montreal 11
Washington 11
Zhengzhou 11
Campinas 10
Mexico City 10
Ningbo 10
Totale 14.087
Salva come PNG Salva come JPEG
Nome #
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures 329
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 327
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 297
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 278
Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1/SPG28 273
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder. 273
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis 270
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 260
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 255
Assessing response to interferon-β in a multicenter dataset of patients with MS 254
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 252
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 251
Automated identification of brain new lesions in multiple sclerosis using subtraction images 251
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes 250
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 244
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 244
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 241
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 241
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 240
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 238
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 236
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 236
Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis. 233
Cortical lesions in radiologically isolated syndrome. 231
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 229
A comparison of cognitive performances between multiple sclerosis patients with pediatric- versus adult onset disease 229
Scoring treatment response in patients with relapsing multiple sclerosis 229
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study 226
Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings 224
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 223
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 223
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 223
Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis 220
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis 218
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 209
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 209
Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy. 208
Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study 207
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 206
Deep gray matter volume loss drives disability worsening in multiple sclerosis 206
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 203
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. 203
Increased QT variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 203
Post-stroke depression: Research methodology of a large multicentre observational study (DESTRO) 200
Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis 200
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. 200
Leukoencephalopathy as a rare complication of hepatitis C infection. 198
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients 198
The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: A Screening Tool to Select Patients for NOTCH3 Gene Analysis. 198
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 193
APOE-{varepsilon}4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. 191
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study 190
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study 190
Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation 188
Rapidly progressive neurodegeneration in a case with the 7472insC mutation and the A7472C polymorphism in the mtDNA tRNA ser(UCN) gene. 188
Diffuse structural and metabolic brain changes in Fabry disease 186
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 185
null 182
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 181
MR evidence of structural and metabolic changes in brains of patients with Werner’s syndrome. 181
The dilemma of benign multiple sclerosis: Can we predict the risk of losing the “benign status”? A 12-year follow-up study 179
Impaired vasoreactivity in mildly disabled CADASIL patients 176
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 174
Cortical functional reorganisation and its relationship with brain structural damage in patients with benign multiple sclerosis 173
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 172
Refining response to treatment as defined by the Modified Rio Score 171
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 167
Modelling the distribution of cortical lesions in multiple sclerosis 166
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course 165
Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With CADASIL: A Randomized Controlled Trial 163
Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study. 163
Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis. 162
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 161
Retinal nerve fibre layer thickness, lesional load and brain atrophy in patients with cerebral autosomal dominant arteriopathy with subcortical infarct and leucoencephalopathy (CADASIL) 156
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 155
Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis 153
Imaging neuronal and axonal degeneration in multiple sclerosis. 152
Structural and Metabolic Brain Abnormalities in Preclinical Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy 151
Mapping the progressive treatment-related reduction of Active MRI lesions in multiple sclerosis 149
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis 148
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 148
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 146
Leukoencephalopathy, cerebral calcifications, and parenchimal cysts in two siblings. 146
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 139
Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm 139
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers 138
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 136
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages 136
Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 135
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis 135
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis 134
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 133
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL, exon 2 mutation. 130
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 127
Short-Term Combination of Glatiramer Acetate with IV Steroid Treatment Preceding Treatment with GA Alone Is Associated with early Suppression of MRI-disease activity in Patients with Relapsing Remitting Multiple Sclerosis 123
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 122
Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients 118
null 117
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 115
Efficacy and safety of intravenous immunoglobulin treatment in refractory Behcet's Disease with different organ involvement: a case series 114
Totale 19.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.213
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021489 0 0 0 0 0 0 0 0 0 163 177 149
2021/20221.441 107 148 99 101 110 70 79 50 79 124 205 269
2022/20231.778 111 151 235 225 160 336 51 155 204 67 53 30
2023/20241.202 61 25 110 48 35 331 429 26 6 25 24 82
2024/20252.931 71 125 240 148 388 164 129 197 230 148 311 780
2025/20266.275 563 920 846 715 1.184 271 868 267 281 360 0 0
Totale 20.604